Intelligence · Drug directory
Withdrawn Drug Applications
Drugs with withdrawn or discontinued regulatory applications in the US or EU — useful for competitive and label-history research.
Quick answer
Withdrawn applications: NovaPharmaNews tracks 229 pharmaceutical drugs in this segment. Drugs with withdrawn or discontinued regulatory applications in the US or EU — useful for competitive and label-history research.
-
pegloticase
KRYSTEXXA
M04AX02 -
porfimer sodium
PHOTOBARR
L01XD01 -
raltegravir potassium
RALTEGRAVIR VIATRIS
J05AJ01 -
saquinavir
FORTOVASE
J05AE01 -
stavudine
ZERIT
J05AF04 -
telbivudine
SEBIVO
J05AF11 -
telithromycin
KETEK
J01FA15 -
valdecoxib
BEXTRA
M01AH03 -
vorinostat
ZOLINZA Merck KGaA, Darmstadt, Germany
-
1-13c-caprylic acid
GASTROMOTAL
-
a/vietnam/1194/2004
AFLUNOV
-
abetimus
RIQUENT
-
abicipar pegol
RAYOQTA
S01LA -
aducanumab
ADUHELM
N07 -
alendronate sodium trihydrate
ALENDRONIC ACID / COLECALCIFEROL MYLAN
M05BB03 -
allogeneic t cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (δlngfr) and the herpes simplex i virus thymidine kinase (hsv-tk mut2)
ZALMOXIS
L01 -
alpha-1-antitrypsin
INFINIA
B02AB02 -
anecortave acetate
RETAANE
-
anti-melanoma mab fragments
TECNEMAB K1
V09IA02 -
antithrombin alfa
ATRYN
B01AB02 -
arachis hypogaea extract
ABYLQIS
V01AA08 -
arcitumomab
CEA-SCAN
V09IA01 -
arimoclomol
MIPLYFFA
N07 -
autologous cartilage-derived articular chondrocytes, in-vitro expanded
JELRIX
M09AX02
Frequently asked questions
How many withdrawn drugs are listed?
229 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.